UK markets closed

Immunicum AB (publ) (IMMU.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
2.4900-0.0100 (-0.40%)
At close: 05:29PM CEST
Currency in SEK

Valuation measures4

Market cap (intra-day) 500.50M
Enterprise value 403.40M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)268.16
Price/book (mrq)0.80
Enterprise value/revenue 224.86
Enterprise value/EBITDA -3.48

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3-42.40%
S&P500 52-week change 3-2.99%
52-week high 36.3400
52-week low 31.7480
50-day moving average 32.2814
200-day moving average 32.8374

Share statistics

Avg vol (3-month) 3328.9k
Avg vol (10-day) 398.5k
Shares outstanding 5199.4M
Implied shares outstanding 6N/A
Float 8114.59M
% held by insiders 158.11%
% held by institutions 112.79%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-6,395.34%

Management effectiveness

Return on assets (ttm)-10.28%
Return on equity (ttm)-19.13%

Income statement

Revenue (ttm)1.8M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)6k
EBITDA -114.16M
Net income avi to common (ttm)-119.42M
Diluted EPS (ttm)-0.6280
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)122.93M
Total cash per share (mrq)0.62
Total debt (mrq)63.35M
Total debt/equity (mrq)10.07
Current ratio (mrq)5.27
Book value per share (mrq)3.16

Cash flow statement

Operating cash flow (ttm)-114.14M
Levered free cash flow (ttm)-81.85M